Anavex Life Sciences Corp (AVXL)

[falconer66a]

In 2022, which disappears, blarcamesine or Aduhelm?

Biogen couldn't even imagine Anavex as a possible solution or future deadly competitor. They were going down with their amyloid ship and are now looking for a tow.

For both Biogen with Aduhelem and Anavex with blarcamesine, 2022 will be the make or break year.

Personally, from what I know of the demonstrated science of each drug, a year from today will see blarcamesine in elevated illumination; Aduhelm as a tragic case study in FDA drug approval malfeasance and adherence to a failed Alzheimer's treatment protocol, forcing the body by extraneous, toxic chemical agents to get rid of various protein wastes.